Introduction
The impact of HIV infection and antiretroviral therapy (ART) on neurocognitive outcomes among children aged 7 to 14 years was assessed. We hypothesized that ART would ameliorate neurocognitive sequelae of HIV infection.
Methods
HIV-positive and negative mother-child pairs from the Rakai Community Cohort Study (RCCS) and ART clinics in Rakai, Uganda were followed prospectively over 4 years. Exposures were stratified as: Perinatally HIV Infected (PHIV), Perinatally HIV Exposed but Uninfected (PHEU), and HIV Unexposed and Uninfected (HUU). The Kaufman Assessment Battery for Children (KABC II) assessed sequential and simultaneous processing, learning, planning, knowledge, and Fluid Crystalized Index (FCI) for overall functioning. Multivariable generalized linear models estimated adjusted Prevalence Rate Ratios (adjPRR) by age.
Results
Of the 370 mother-child pairs, 55% were HUU, 7% were PHEU and 37.9% were PHIV. Among HIV infected children, longer duration of ART was associated with a significant improvement of sequential processing skills (adj.PRR 25–36 months: 0.55, 95% CI: 0.34–0.9; 37–48 months: 0.39, 95%CI 0.2–0.76; 49+ months 0.23, 95% CI: 0.1–0.54). Each additional year of schooling was associated with a 30–40% decrease of impairment for all neurocognitive measures assessed. Healthier children (higher age standardized height and weight), had improved sequential and simultaneous processing and overall FCI.
Conclusions
Sequential processing skills of working memory improved with prolonged ART and increased duration of schooling was associated with a reduction of neurocognitive impairment. Early initiation and sustained use of ARTs and longer schooling are needed to reduce neurocognitive impairment among HIV infected, school aged children.